Effects of insulin glargine versus metformin on glycemic variability, microvascular and beta-cell function in early type 2 diabetes. - CRS. Experts. Early Phase.

Effects of insulin glargine versus metformin on glycemic variability, microvascular and beta-cell function in early type 2 diabetes.

Science

ShareTwitter FacebookXingLinkedin

First published in Acta Diabetologica in 2013 Aug.
Acta Diabetol. 2013 Aug;50(4):587-95. doi: 10.1007/s00592-012-0451-9. Epub 2013 Feb 21.

Authors: Pistrosch F, Köhler C, Schaper F, Landgraf W, Forst T, Hanefeld M

Read more

Download full article as Pdf file:

REACHING OUT IS EASY AND FAST – LET’S TALK

Prof. Dr. Thomas Forst

Chairman of the Executive Board

LET’S TALK SCIENCE

+49 621 150 45 – 0

Martin Mulder

Senior Vice President Corporate & Business Development

LET’S TALK BUSINESS

+49 621 150 45 – 0

beta cell function continuous glucose monitoring efficacy Insulin microcirculation oral anti diabetic drugs pharmacodynamics Type 2 diabetes

You May Also Like

Science 25. Mai 2023

CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes

Science 25. Mai 2023

Efficacy and safety of the ghrelin-O-acyltransferase inhibitor BI 1356225 in overweight/obesity: Data from two Phase I, randomised, placebo-controlled studies.

Science 25. Mai 2023

(Bersacapavir) In Participants With Moderate Hepatic Impairment.